| abstract |
Alpha radionuclides (eg astatine-211) to increase the efficacy of the formulation and / or large molecules (eg oligomers / polymers such as PEG or dextrin or ficoll (registered) to reduce filtration and thus kidney exposure Certain 3,3 ′, 4,4′-tetrahydroxy-2,2′-bipyridine-N, N′-dioxide compounds, especially 3,3 ′, A method for treating renal cancer by administration of 4,4′-tetrahydroxy-2,2′-bipyridine-N, N′-dioxide (olelanin). Certain administration protocols and administration regimes and pharmaceutical compositions suitable for use in the methods of treatment can be used. |